ZMYND8
protein-codingzinc finger MYND-type containing 8, the group of Zinc fingers MYND-type|PWWP domain containing|Bromodomain containing|PHD finger proteins
Gene summary
The protein encoded by this gene is a receptor for activated C-kinase (RACK) protein. The encoded protein has been shown to bind in vitro to activated protein kinase C beta I. In addition, this protein is a cutaneous T-cell lymphoma-associated antigen. Finally, the protein contains a bromodomain and two zinc fingers, and is thought to be a transcriptional regulator. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- PRKCBP1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~147.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0800439
Submitter: ClinGen
*ZMYND8* encodes a multidomain protein that is part of an extensive network of protein-protein interactions involved in transcription regulation, chromatin remodeling, super-enhancer regulation, DNA damage response, and tumor suppression. *ZMYND8* was first reported in relation to autosomal dominant syndromic complex neurodevelopmental disorder in 2022 (Dias et al., PMID: 35916866). Most affected individuals present with mild to moderate intellectual disability, language deficits, variable dysmorphic facial features, congenital cardiac defects, skeletal anomalies, and hearing or visual impairment (PMID: 35916866). Other more variable features include autism spectrum disorder or autistic behavior, seizures, poor growth, and respiratory tract anomalies. Thirteen variants (8 missense, 4 frameshift, and 1 nonsense) reported in 15 probands in five publications (PMIDs: 31981491, 32530565, 33057194, 35916866, 35982159) are included in this curation. All the variants with available parental information were *de novo*. The mechanism of pathogenicity is reported to be dominant negative for missense variants and loss of function for truncating variants (PMID: 35916866). All missense variants were located in functional domains or motifs; four variants were shown to affect the interaction with the neuronal actin-binding protein drebrin or with the NuRD complex subunit GATAD2A (PMID: 35916866). This gene-disease relationship is also supported by a *Drosophila* model with neuronal knockdown of *Zmynd8* that exhibits decreased habituation learning (PMID: 35916866). In summary, there is definitive evidence supporting the relationship between *ZMYND8* and autosomal dominant syndromic complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on February 19, 2025 (SOP Version 11). It was reevaluated on March 9, 2026. As a result of this reevaluation, the classification changed from strong to definitive as three years have passed from the original discovery publication date. Since no changes were made to the evidence or scoring, the SOP version remains 11.
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0005258
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZMYND8 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001281775.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 11 | 2 | 17 | ||
| missense | 3 | 151 | 13 | 1 | 168 | |
| nonsense | 1 | 6 | 7 | |||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 5 | 8 | ||
| splice donor/acceptor (+/-2bp) | 8 | 8 | ||||
| Total | 2 | 5 | 174 | 24 | 3 | 208 |
Highest pathogenic variant AF is 0.0000013681089
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001268704.1 | 23 | MANE Select | |
| Ensembl | ENSP00000420095.2 | 23 | MANE Select | |
| RefSeq | NP_001268698.1 | 4 | Standard | |
| RefSeq | NP_001268700.1 | 21 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription, DNA-templated
- negative regulation of cell migration
- positive regulation of filopodium assembly
- positive regulation of dendritic spine development
- modulation of excitatory postsynaptic potential
Molecular Function
- transcription corepressor activity
- protein binding
- zinc ion binding
- protein domain specific binding
- methylated histone binding
Cellular Component
- nucleus
- cytoplasm
- dendritic spine
- dendritic shaft
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000461685
- Coding exons
- 23
- Length
- 147709
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125747
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.04 | 399 | 700 | 0.570 | 0.0000419 | 7862 |
| Missense (PolyPhen) | 80 | 234.01 | 0.34187 | 2776 | ||
| Synonymous | -0.387 | 294 | 286 | 1.03 | 0.0000204 | 2207 |
| Loss of Function | 6.77 | 3 | 59.2 | 0.0507 | 0.00000285 | 719 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000045 | 0.000044 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May act as a transcriptional corepressor for KDM5D. Required for KDM5D-mediated down-regulation of diverse metastasis- associated genes; the function seems to involve the recognition of the dual histone signature H3K4me1-H3K14ac. Suppresses prostate cancer cell invasion. {ECO:0000269|PubMed:27477906}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- LoFtool
- 0.0152
- RVIS EVS
- -1.44
- RVIS percentile EVS
- 3.98
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |